BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6358997)

  • 1. Effect of Sialor in treatment of xerostomia in Sjögren's syndrome.
    Epstein JB; Decoteau WE; Wilkinson A
    Oral Surg Oral Med Oral Pathol; 1983 Nov; 56(5):495-9. PubMed ID: 6358997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of a sialogogue in humans: a preliminary report.
    Epstein JB
    Spec Care Dentist; 1982; 2(1):17-9. PubMed ID: 6951304
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Saliment on parotid salivary gland secretion and on xerostomia caused by Sjögren's syndrome.
    Donatsky O; Johnsen T; Holmstrup P; Bertram U
    Scand J Dent Res; 1982 Apr; 90(2):157-62. PubMed ID: 7041242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of xerostomia in patients with primary Sjögren's syndrome with sulfarlem.
    Schiødt M; Oxholm P; Jacobsen A
    Scand J Rheumatol Suppl; 1986; 61():250-2. PubMed ID: 3473639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study with a sialagogue drug (sulfarlem S 25 = TTPT) in the treatment of xerostomia (author's transl)].
    Häusler R; Ritschard J
    Schweiz Rundsch Med Prax; 1979 Aug; 68(33):1063-8. PubMed ID: 471936
    [No Abstract]   [Full Text] [Related]  

  • 6. Prosthetic management of Sjörgren's syndrome.
    Slabbert JC; Raubenheimer EJ
    J Dent Assoc S Afr; 1978 Nov; 33(11):597-601. PubMed ID: 295313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience in the treatment of non-iatrogenic xerostomia and xerophthalmia with trithioparamethoxyphenylpropene].
    Bianucci G; Campana G; Maddali Bongi S; Castagnoli A; Passigli G
    Clin Ter; 1984 Jun; 109(5):417-27. PubMed ID: 6236932
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xerostomia due to Sjögren's syndrome. Diagnostic criteria, treatment and outlines for a continuous dental care programme and an open trial with Sulfarlem.
    Malmström MJ; Segerberg-Konttinen M; Tuominen TS; Hietanen JH; Wolf JE; Sane JI; Konttinen YT
    Scand J Rheumatol; 1988; 17(2):77-86. PubMed ID: 3291100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
    Erlichman M
    Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia in Sjögren's syndrome treated with Sali-Synt. A double-blind cross-over trial.
    Kaarela K; Mutru O
    Scand J Rheumatol; 1982; 11(1):39-40. PubMed ID: 7038859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of xerostomia: a double-blind trial in 108 patients with Sjögren's syndrome.
    Klestov AC; Webb J; Latt D; Schiller G; McNamara K; Young DY; Hobbes J; Fetherston J
    Oral Surg Oral Med Oral Pathol; 1981 Jun; 51(6):594-9. PubMed ID: 7019805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of SL 25 on radiogenic xerostomia in the radiotherapy of tumors in the region of neck and face (author's transl)].
    Hassenstein E; Müller R; Reinhard HJ
    Strahlentherapie; 1978 Aug; 154(8):554-8. PubMed ID: 356350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of sialagogues in management of xerostomia after radiation therapy.
    Epstein JB; Schubert MM
    Oral Surg Oral Med Oral Pathol; 1987 Aug; 64(2):179-82. PubMed ID: 3306552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of drug-induced dryness of the mouth].
    Durst W
    Ther Ggw; 1978 Jul; 117(7):1102-10. PubMed ID: 675568
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sjögren's syndrome in the elderly].
    Gentric-Tilly A
    Ann Med Interne (Paris); 2002 Oct; 153(6):378-82. PubMed ID: 12486386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjogren's syndrome: oral and dental considerations.
    Atkinson JC; Fox PC
    J Am Dent Assoc; 1993 Mar; 124(3):74-6, 78-82, 84-6. PubMed ID: 8335784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis and Sjögren's syndrome: clinical and salivary evaluation.
    Mansour MJ; He C; Al-Farra ST; Khuder SA; Wright JM; Kessler HP; Hinton RJ; Al-Hashimi I
    J Oral Pathol Med; 2013 Sep; 42(8):594-9. PubMed ID: 23480241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.